A Clinicopathological Study of 29 Spitzoid Melanocytic Lesions With ALK Fusions, Including Novel Fusion Variants, Accompanied by Fluorescence In Situ Hybridization Analysis for Chromosomal Copy Number Changes, and Both TERT Promoter and Next-Generation Sequencing Mutation Analysis

The American Journal of Dermatopathology
Liubov KastnerovaDmitry V Kazakov

Abstract

ALK-fused spitzoid neoplasms represent a distinctive group of melanocytic lesions. To date, few studies addressed genetic and chromosomal alterations in these lesions beyond the ALK rearrangements. Our objective was to study genetic alterations, including ALK gene fusions, telomerase reverse transcriptase promoter (TERT-p) mutations, chromosomal copy number changes, and mutations in other genes. We investigated 29 cases of Spitz lesions (11 Spitz nevi and 18 atypical Spitz tumors), all of which were ALK immunopositive. There were 16 female and 13 male patients, with age ranging from 1 to 43 years (mean, 18.4 years). The most common location was the lower extremity. Microscopically, all neoplasms were polypoid or dome shaped with a plexiform, predominantly dermally located proliferation of fusiform to spindled melanocytes with mild to moderate pleomorphism. The break-apart test for ALK was positive in 17 of 19 studied cases. ALK fusions were detected in 23 of 26 analyzable cases by Archer FusionPlex Solid Tumor Kit. In addition to the previously described rearrangements, 3 novel fusions, namely, KANK1-ALK, MYO5A-ALK, and EEF2-ALK, were found. Fluorescence in situ hybridization for copy number changes yielded one case with the lo...Continue Reading

References

Nov 1, 1989·The American Journal of Surgical Pathology·K J SmithJ H Graham
Nov 15, 1995·Cancer·R L BarnhillA Perez-Atayde
Mar 23, 1999·Archives of Dermatology·A SpatzR L Barnhill
Dec 14, 1999·The Journal of Investigative Dermatology·B C BastianP E Leboit
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·J K KarowI D Hickson
Sep 26, 2003·Journal of Cutaneous Pathology·Mai P Hoang
Feb 1, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Raymond L Barnhill
Feb 4, 2006·The American Journal of Dermatopathology·Raymond L Barnhill
Mar 26, 2009·The American Journal of Dermatopathology·Celia RequenaEvaristo Sánchez Yus
Jun 26, 2009·Cellular and Molecular Life Sciences : CMLS·N KakinumaR Kiyama
Apr 1, 2010·Nature Methods·Ivan A AdzhubeiShamil R Sunyaev
Nov 4, 2010·Cancer Biomarkers : Section a of Disease Markers·Anjali SrivastavaXimena Leighton
Nov 6, 2010·Seminars in Cutaneous Medicine and Surgery·Maria Miteva, Rossitza Lazova
Feb 18, 2011·Genes & Development·Amitabh V NimonkarStephen C Kowalczykowski
May 10, 2011·Clinics in Laboratory Medicine·Daniel C Zedek, Timothy H McCalmont
May 17, 2012·The American Journal of Surgical Pathology·Pedram GeramiKaterina Pestova
Feb 8, 2013·The American Journal of Surgical Pathology·Pedram GeramiKlaus Busam
Apr 27, 2013·Bioinformatics·Hashem A ShihabTom R Gaunt
Jun 19, 2013·International Journal of Surgical Pathology·Gerardo FerraraAnnalisa Patrizi
Jun 26, 2013·The American Journal of Surgical Pathology·Pedram GeramiRaymond L Barnhill
Jan 22, 2014·Nature Communications·Thomas WiesnerBoris C Bastian
Feb 27, 2014·Nature Communications·Barbara HeidenreichRajiv Kumar
Apr 5, 2014·The American Journal of Surgical Pathology·Klaus J BusamThomas Wiesner
Apr 17, 2014·The American Journal of Dermatopathology·Jose A PlazaDmitry V Kazakov
Jan 21, 2015·The American Journal of Surgical Pathology·Iwei YehBoris C Bastian
Feb 14, 2016·International Journal of Surgical Pathology·Maija KiuruKlaus J Busam
Feb 20, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Gang WuArmita Bahrami
Mar 5, 2016·Expert Review of Anticancer Therapy·Federica Zito MarinoRenato Franco
Mar 30, 2016·Pathology·Daniela MassiMario Mandalà
Jul 9, 2016·The American Journal of Dermatopathology·Christina Y LeePedram Gerami
Oct 21, 2016·The Journal of Pathology·Iwei YehBoris C Bastian
Aug 19, 2016·Nature·Monkol LekUNKNOWN Exome Aggregation Consortium
Oct 25, 2016·The American Journal of Surgical Pathology·Sapna M AminPedram Gerami
Feb 12, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Rossitza LazovaMichael Krauthammer
Apr 11, 2017·The American Journal of Dermatopathology·Angel Fernandez-FloresDavid S Cassarino
Oct 14, 2017·Journal of Cutaneous Pathology·Andrew J RandJulie D R Reimann

❮ Previous
Next ❯

Citations

Dec 3, 2020·The American Journal of Dermatopathology·Michele DonatiDmitry V Kazakov
Aug 28, 2021·Dermatopathology·Arnaud de la FouchardièreNicolas Macagno

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.